GE Healthcare debuted the Discovery MI and the Discovery NM/CT 670 CZT molecular imaging systems at the Society of Nuclear Medicine and Molecular Imaging’s 2016 annual meeting in San Diego last week. Both systems are geared toward delivering quantitative results for patients and feature the latest digital detectors in molecular imaging.
Xeleris 4.0—a new nuclear medicine workstation that helps clinicians complete customizable reports across multiple care areas—supports the Discovery NM/CT.
Moreover, Discovery MI was created to help clinicians diagnose disease earlier and better guide treatment strategies. It also helps clinicians with research, such as quantitative brain studies, using an expanded field of view. What’s more, the 510(k)-pending scanner offers low-yield tracer capabilities with protocols that reduce radiation dose by up to 50%.
Finally, the Discovery NM/CT 670 CZT improves lesion detection and enables clinicians to monitor diseases earlier, thanks to the Xeleris 4.0. This nuclear medicine/CT system will also help clinicians simultaneously visualize and analyze multiple physiological processes in a patient.
For more information about these systems, visit GE Healthcare.